Niranjan Y. Sardesai
Director Ejecutivo en Geneos Therapeutics, Inc. .
Cargos activos de Niranjan Y. Sardesai
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Geneos Therapeutics, Inc.
 Geneos Therapeutics, Inc. BiotechnologyHealth Technology Geneos Therapeutics, Inc. Develops and commercializes neo-antigen based personalized cancer therapies. The firm engages in developing personalized immunotherapies against tumor specific neoantigens which arise from gene mutations in cancerous cells. The company was founded by Niranjan Y. Sardesai in 2017 and is headquartered in Plymouth Meeting, PA. | Director Ejecutivo | 01/01/2017 | - |
| Fundador | 01/01/2017 | - | |
| Presidente | 01/01/2017 | - |
Historial de carrera de Niranjan Y. Sardesai
Antiguos cargos conocidos de Niranjan Y. Sardesai.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| INOVIO PHARMACEUTICALS, INC. | Director de Operaciones | 01/06/2009 | 21/02/2019 |
| Director Técnico/Científico/I+D | 01/06/2009 | 05/01/2012 | |
VGX Pharmaceuticals LLC
 VGX Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology VGX Pharmaceuticals LLC develops pharmaceuticals. The company was founded by J. Joseph Kim and is headquartered in Blue Bell, PA. | Director Técnico/Científico/I+D | 01/11/2007 | 01/11/2007 |
| Nvision Consulting, Inc. | Fundador | 01/06/2005 | 01/09/2006 |
| Presidente | - | 01/09/2006 | |
Fujirebio Diagnostics, Inc.
 Fujirebio Diagnostics, Inc. Medical SpecialtiesHealth Technology Fujirebio Diagnostics, Inc. develops, manufactures and commercializes in-vitro diagnostic products. Its products include oncology RIA and EIA kits, veterinary products and research kits. The company was founded in 1965 and is headquartered in Malvern, PA | Director Técnico/Científico/I+D | 01/12/2005 | 01/12/2005 |
IGEN International, Inc.
 IGEN International, Inc. Medical SpecialtiesHealth Technology IGEN International, Inc. develops and markets biological testing systems that incorporate its proprietary electrochemiluminescence technology for used in drug discovery, diagnostic products development as well as food and environmental safety testing. The company was founded in 1982 and is headquartered in Gaithersburg, MD. | Director Técnico/Científico/I+D | - | - |
Formación de Niranjan Y. Sardesai.
| California Institute of Technology | Doctorate Degree |
| Indian Institute of Technology Bombay | Graduate Degree |
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
Estadísticas
Internacional
| Estados Unidos | 9 |
| India | 2 |
Operativa
| Chief Tech/Sci/R&D Officer | 4 |
| Founder | 2 |
| President | 2 |
Sectorial
| Health Technology | 6 |
| Consumer Services | 4 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| INOVIO PHARMACEUTICALS, INC. | Health Technology |
| Empresas privadas | 5 |
|---|---|
| Nvision Consulting, Inc. | |
Fujirebio Diagnostics, Inc.
Fujirebio Diagnostics, Inc. Medical SpecialtiesHealth Technology Fujirebio Diagnostics, Inc. develops, manufactures and commercializes in-vitro diagnostic products. Its products include oncology RIA and EIA kits, veterinary products and research kits. The company was founded in 1965 and is headquartered in Malvern, PA | Health Technology |
IGEN International, Inc.
IGEN International, Inc. Medical SpecialtiesHealth Technology IGEN International, Inc. develops and markets biological testing systems that incorporate its proprietary electrochemiluminescence technology for used in drug discovery, diagnostic products development as well as food and environmental safety testing. The company was founded in 1982 and is headquartered in Gaithersburg, MD. | Health Technology |
VGX Pharmaceuticals LLC
VGX Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology VGX Pharmaceuticals LLC develops pharmaceuticals. The company was founded by J. Joseph Kim and is headquartered in Blue Bell, PA. | Health Technology |
Geneos Therapeutics, Inc.
Geneos Therapeutics, Inc. BiotechnologyHealth Technology Geneos Therapeutics, Inc. Develops and commercializes neo-antigen based personalized cancer therapies. The firm engages in developing personalized immunotherapies against tumor specific neoantigens which arise from gene mutations in cancerous cells. The company was founded by Niranjan Y. Sardesai in 2017 and is headquartered in Plymouth Meeting, PA. | Health Technology |
- Bolsa de valores
- Insiders
- Niranjan Y. Sardesai
- Experiencia
